drugset / Trial / NCT02249052
Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether collagenase is effective in reducing the surface area of a subcutaneous benign lipoma.
Timeline
- Start
- 2014-08
- Primary completion
- 2016-04
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Collagenase Clostridium Histolyticum | Protein / enzyme biologic | 0.58 mg | — |